Cancer in South West Queensland

 

   

The CCQ region of South West Queensland covers nearly a quarter of Queensland (24% or 407,000 km2), including the most southern and south west areas of the State. In 2019 it had a population of almost 349,458, which was 6.9% of Queensland’s total population.
 

The major population centres are Toowoomba, Dalby and Charleville. Significant industries include agriculture, cotton farming, cattle grazing, natural resource extraction and tourism. The nearest radiation treatment centre for cancer patients in South West Queensland is in Toowoomba. Radiation facilities are also available in Brisbane, Gold Coast and Sunshine Coast.

   

Region Characteristics (2019 data unless otherwise specified) South West Queensland Queensland
Percent of population who…
… are female 50.4% 50.6%
… are aged 50 years and over 24.4% 22.7%
… are Indigenous (2016) 6.3% 4.6%
… speak another language at home 5.5% 12.1%
… live in remote areas 4.9% 2.0%
… live within 2 hours drive of radiation treatment 81.8% 89.5%
… live more than 6 hours drive from radiation treatment 2.0% 1.8%
… live in disadvantaged areas 28.5% 17.7%
… live in affluent areas 8.5% 18.8%
All Cancers* South West Queensland Male Female Persons
Number of new cases per year 1306 1029 2335
Chance of diagnosis by age 80* 1 in 2.1 1 in 2.7 1 in 2.4
Median age at diagnosis 69 yrs 67 yrs 68 yrs
Five-year relative survival 68% 73% 70%
Number of deaths per year 417 314 732
Percent deaths before age 80 67% 64% 66%
1 Persons data may not equal sum of males and females due to rounding.
2 Cancers with a lifetime risk above 1 in 5 the value provided to one decimal point.

The 10 most common cancers diagnosed in South West Queensland by sex, 2015 - 2019

Five-year relative survival in South West Queensland by type of cancer and sex, 2015 - 2019

Note: Relative survival calculated using the period method, for persons aged 0-89 years at diagnosis. Data are for “at risk” cases in the period 2015-2019

Facts about the most common cancers in South West Queensland

Colorectal Cancer Male Female Persons
Number of new cases per year 151 123 274
Chance of diagnosis by age 80* 1 in 15 1 in 21 1 in 17
Median age at diagnosis 70 yrs 73 yrs 71 yrs
Five-year relative survival 69% 67% 68%
Number of deaths per year 48 45 93
Percent deaths before age 80 63% 52% 58%
Lung Cancer Male Female Persons
Number of new cases per year 107 74 181
Chance of diagnosis by age 80* 1 in 20 1 in 28 1 in 24
Median age at diagnosis 72 yrs 70 yrs 71 yrs
Five-year relative survival 12% 22% 16%
Number of deaths per year 85 56 142
Percent deaths before age 80 75% 80% 77%
Melanoma Male Female Persons
Number of new cases per year 183 151 333
Chance of diagnosis by age 80* 1 in 12 1 in 15 1 in 13
Median age at diagnosis 66 yrs 63 yrs 65 yrs
Five-year relative survival 92% 95% 93%
Number of deaths per year 17 9 26
Percent deaths before age 80 71% 59% 67%
Female Breast Cancer Male Female Persons
Number of new cases per year . . . . . . 254 . . . . . .
Chance of diagnosis by age 80* . . . . . . 1 in 9 . . . . . .
Median age at diagnosis . . . . . . 64 yrs . . . . . .
Five-year relative survival . . . . . . 90% . . . . . .
Number of deaths per year . . . . . . 46 . . . . . .
Percent deaths before age 80 . . . . . . 69% . . . . . .
Prostate Cancer Male Female Persons
Number of new cases per year 350 . . . . . . . . . . . .
Chance of diagnosis by age 80* 1 in 6 . . . . . . . . . . . .
Median age at diagnosis 69 yrs . . . . . . . . . . . .
Five-year relative survival 90% . . . . . . . . . . . .
Number of deaths per year 55 . . . . . . . . . . . .
Percent deaths before age 80 44% . . . . . . . . . . . .

More details on the top 10 cancers diagnosed in South West Queensland

Persons
Incidence (a)
Mortality (a)
Type of cancer Average no. per year Annual rate (per 100,000 (b) Five-year relative survival (%) (c) Average no. per year Annual rate (per 100,000) (b)
All invasive cancers 2335 535 [525,545] 70 [69,71] 732 158 [153,163]
Prostate cancer 350 n.a. 90 [88,92] 55 n.a.
Melanoma 333 82 [78,86] 93 [91,95] 26 6 [5,7]
Colorectal cancer 274 62 [58,65] 68 [65,71] 93 20 [18,22]
Female breast cancer 254 n.a. 90 [88,92] 46 n.a.
Lung cancer 181 39 [36,41] 16 [13,18] 142 30 [28,32]
Non-Hodgkin lymphoma 70 16 [14,18] 74 [68,79] 18 4 [3,5]
Kidney cancer 67 16 [14,17] 72 [66,78] 20 4 [4,5]
Pancreatic cancer 54 12 [11,13] 12 [8,17] 43 9 [8,11]
Thyroid cancer 46 12 [11,14] 98 [94,100] ** **
Bladder cancer 45 10 [8,11] 55 [47,63] 17 4 [3,5]
Males
Incidence (a)
Mortality (a)
Type of cancer Average no. per year Annual rate (per 100,000 (b) Five-year relative survival (%) (c) Average no. per year Annual rate (per 100,000) (b)
All invasive cancers 1306 607 [592,622] 68 [66,69] 417 193 [184,201]
Prostate cancer 350 153 [146,160] 90 [88,92] 55 26 [23,29]
Melanoma 183 91 [85,98] 92 [89,94] 17 8 [7,10]
Colorectal cancer 151 70 [65,76] 69 [65,73] 48 23 [20,26]
Lung cancer 107 48 [44,52] 12 [9,15] 85 38 [35,42]
Kidney cancer 45 21 [18,24] 69 [62,76] 14 7 [5,9]
Non-Hodgkin lymphoma 41 19 [17,22] 71 [63,78] 12 5 [4,7]
Bladder cancer 32 14 [12,17] 56 [46,64] 11 5 [4,7]
Pancreatic cancer 28 13 [11,15] 12 [7,19] 21 10 [8,12]
Lymphoid leukaemia 28 13 [11,15] 82 [73,89] 6 3 [2,4]
Stomach cancer 24 11 [9,13] 29 [20,38] 16 8 [6,10]
Females
Incidence (a)
Mortality (a)
Type of cancer Average no. per year Annual rate (per 100,000 (b) Five-year relative survival (%) (c) Average no. per year Annual rate (per 100,000) (b)
All invasive cancers 1029 470 [457,483] 73 [71,74] 314 129 [122,136]
Breast cancer 254 118 [112,125] 90 [88,92] 46 20 [17,23]
Melanoma 151 73 [67,78] 95 [92,97] 9 4 [3,5]
Colorectal cancer 123 53 [49,58] 67 [62,71] 45 18 [15,20]
Lung cancer 74 31 [28,34] 22 [17,27] 56 23 [20,26]
Uterine cancer 43 19 [17,22] 83 [76,89] 7 3 [2,4]
Thyroid cancer 33 18 [15,21] 99 [95,101] ** **
Non-Hodgkin lymphoma 29 13 [11,16] 78 [68,85] 6 2 [1,3]
Pancreatic cancer 26 11 [9,13] 11 [6,18] 22 9 [7,11]
Kidney cancer 23 10 [8,12] 79 [69,87] 6 2 [2,3]
Ovarian cancer 21 9 [8,11] 38 [28,48] 15 6 [5,8]
Note:
n.a. = not applicable (rates for persons not applicable for sex-specific cancers)

** Incidence or mortality counts that averaged less than five per year (and the corresponding rates) have been suppressed to protect confidentiality. Counts and rates for persons have also been suppressed when necessary
a Incidence and mortality data are averaged over the 5 year period from 2015-2019.
b Incidence and mortality rates have been directly age-standardised to the 2001 Australian Standard population, with 95% confidence intervals shown in brackets.
c Five-year relative survival calculated using the period method, for persons aged 0-89 years at diagnosis, with 95% confidence intervals shown in brackets. Estimates are for “at risk” cases in the period 2015-2019
d Persons data may not equal the sum of males and females due to rounding

             

Methodology

1. All cancer data are sourced from the Queensland Cancer Register. The access and use of these data for reporting purposes is subject to strict confidentiality and privacy constraints.
2. Census and population data were obtained from the Australian Bureau of Statistics.
3. Population death data used in relative survival calculations were obtained from the Australian Coordinating Registry of Births, Deaths and Marriages.
4. All calculations were performed using Stata v16.1.
5. Trend lines for incidence numbers have been smoothed using the ‘Lowess’ method.
6. Remote areas are defined by the Remoteness Areas 2016 classification (combines Remote and Very Remote).
7. Travelling times to radiation treatment are calculated using spatial and road network software, and are approximate based on the shortest road distances at the recommended speed limits.
8. ‘Affluent areas’ are the 20% of most advantaged Statistical Areas 2 (SA2s) and ‘Disadvantaged areas’ are the 20% of most disadvantaged SA2s as defined by the 2016 SEIFA Index of Advantage and Disadvantage obtained from the Australian Bureau of Statistics.
9. Relative survival compares overall survival among those diagnosed with cancer to the expected survival of the general population, taking into account age, sex and year of diagnosis.

 

Disclaimer: The information in this publication should not be used as a substitute for advice from a properly qualified medical professional who can advise you about your own individual medical needs. It is not intended to constitute medical advice and is provided for general information purposes only. Information on cancer, including the diagnosis, treatment and prevention of cancer, is constantly being updated and revised by medical professionals and the research community. Cancer Council Queensland does not warrant that the information in this publication is correct, up to date or complete nor that it is suitable for any particular purpose. Your use of the information in this publication is at your own risk. To the fullest extent permitted by law, Cancer Council Queensland does not accept any liability for any reliance placed on information that is not correct, complete or up to date, or that is not suited to the purpose for which it was relied upon. If any warranty or guarantee cannot by law be excluded, then, to the extent permitted by law, Cancer Council Queensland’s liability for such warranty or guarantee is limited, at Cancer Council Queensland’s option, to supplying the information or materials again or paying the cost of having the information or materials supplied again.